Screener
Maze Therapeutics MAZE Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$44.73M-32.8% | -$24.21M+26.2% | -$34.57M— | -$30.09M-21.6% | -$33.68M-124% | ||
| $391K-39.8% | $444K-35.1% | $499K-29.2% | $571K-27.5% | $649K-24.0% | ||
| $9.19M+184% | $7.11M+120% | $6.07M+113% | $3.86M+64.9% | $3.24M+51.1% | ||
| -$15.05M+49.9% | -$39.11M-32.5% | -$27.73M— | -$24.64M— | -$30.05M-121% | ||
| $107K-72.8% | $93K-68.9% | $34K-94.4% | $68K-34.0% | $393K+146% | ||
| -$128.51M-32,599% | $6.28M+2,199% | -$103.39M-16,989% | -$66.88M-64,835% | -$393K-146% | ||
| —— | $39.4M— | —— | —— | —— | ||
| $147.44M+23,991% | $42.36M-66.7% | $3.59M-94.9% | $143.76M— | $612K+297% | ||
| $3.88M+113% | $9.52M-90.2% | -$127.53M-370% | $52.23M— | -$29.83M-121% | ||
| -$15.16M+50.2% | -$39.21M-31.5% | -$27.76M— | -$24.71M— | -$30.45M-121% |
FAQ
- How much cash does Maze Therapeutics generate?
- Maze Therapeutics (MAZE) generated -$106.5M in operating cash flow over the trailing twelve months.
- What is Maze Therapeutics's free cash flow?
- After $302.0K of capital expenditures, Maze Therapeutics's free cash flow was -$106.8M over the trailing twelve months, down 275.4% year over year.
- Where does Maze Therapeutics's cash flow data come from?
- Every line is extracted from Maze Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.